drugset / Trial / NCT07174011

Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata

NCT07174011

Phase 4 Completed 50 enrolled Cairo University
RandomizedParallel-groupDouble-blindTreatment

Summary

Evaluation of the Efficacy and Safety of a drug called Oral Roflumilast versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata.

Timeline

Start
2025-01-12
Primary completion
2025-05-20
Completion
2025-08-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Roflumilast Small molecule 500 ug Oral

Indications